Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics
It is proposed that the strategic integration of genome-wide analyses, sequencing, multi-omics data, and hypothesis-driven genetic studies may accelerate the clinical adoption of pharmacogenetics and contribute to more effective precision medicine in psychiatry.